Hypertrophic cardiomyopathy mutations along the myosin mesa may increase cardiac muscle power output by releasing the inhibitory effect of myosin-binding protein C.
Tasa de eventos absoluta: 0% vs 0%
No matter how many times one explores the structure of the myosin molecule, there is always something new to discover. Here, I describe the myosin mesa, a structural feature of the motor domain that has the characteristics of a binding domain for another protein, possibly myosin-binding protein C (MyBP-C). Interestingly, many well-known hypertrophic cardiomyopathy (HCM) mutations lie along this surface and may affect the putative interactions proposed here. A potential unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy is discussed here. It involves increased power output of the cardiac muscle as a result of HCM mutations causing the release of inhibition by myosin binding protein C.
James A. Spudich (Mon,) reported a other. Hypertrophic cardiomyopathy mutations along the myosin mesa may increase cardiac muscle power output by releasing the inhibitory effect of myosin-binding protein C.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: